Evidence map›Paper›PMID 41982418›Full record

ArticleFrontiers in neurology

Beyond

Magdalena Krygier, Emilia J Sitek, Magdalena Chylińska, Szymon Ziętkiewicz, Marta Zawadzka, Jarosław Dulski, Michał Schinwelski, Grażyna Kostrzewa, Jolanta Wierzba, Rafał Płoski and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Magdalena KrygierDepartment of Developmental Neurology, Medical University of Gdańsk, Gdańsk, Poland.
Emilia J SitekLaboratory of Clinical Neuropsychology, Neurolinguistics and Neuropsychotherapy, Division of Neurological and Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdańsk, Gdańsk, Poland.
Magdalena ChylińskaDepartment of Adult Neurology, Medical University of Gdańsk, Gdańsk, Poland.
Szymon ZiętkiewiczIntercollegiate Faculty of Biotechnology, University of Gdańsk, Gdańsk, Poland.
Marta ZawadzkaDepartment of Developmental Neurology, Medical University of Gdańsk, Gdańsk, Poland.
Jarosław DulskiDepartment of Neurology, St. Adalbert Hospital, Copernicus PL Ltd., Gdansk, Poland.
Michał SchinwelskiDivision of Neurological and Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdańsk, Gdańsk, Poland.
Grażyna KostrzewaDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Jolanta WierzbaDepartment of Internal and Pediatric Nursing, Institute of Nursing and Midwifery, Medical University of Gdańsk, Gdańsk, Poland.
Rafał PłoskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Michael ZechInstitute of Human Genetics, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Maria Mazurkiewicz-BełdzińskaDepartment of Developmental Neurology, Medical University of Gdańsk, Gdańsk, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myoclonus-dystonia syndrome (MDS) is a clinically and genetically heterogeneous movement disorder characterized by myoclonus and dystonia as its core features. While mutations in the

Indexed as

dystoniaKCNN2KCTD17memory impairmentmyoclonusneuropsychiatric symptomspediatric movement disordersSGCE

Identifiers

PMID41982418
PMCPMC13070805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.